Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CD34 may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. Additionally we are shipping CD34 Antibodies (952) and CD34 Proteins (28) and many more products for this protein.
Showing 3 out of 15 products:
Aging induces loss of stemness with concomitant gain of myogenic properties of a pure population of CD34+/CD45 (show PTPRC ELISA Kits)- muscle derived stem cells.
Stem cell factor (show KITLG ELISA Kits) is essential for preserving reconstitution capacity of ex vivo expanded cord blood CD34(+) cells in Immunocompromised mice.
combinatorial expression of CD105 and CD34 receptors controls bone morphogenetic protein responsiveness in adipose-derived stem cells
Our results suggest that CD34+ cells may represent the adipose-derived mesenchymal stem cells which possess stronger multiple differentiation potential during reconstituted skin development
Data suggest that CD34 may be a specific marker for functionality, with some specificity for insulin (show INS ELISA Kits).
murine in vitro expanded bone marrow-derived murine mesenchymal stem cells can transform into CD34 expressing cells that induce sarcoma formation in vivo.
Blood-borne CD34(+) endothelial progenitor cells, characterized by active cell division and an amplified transcriptional signature, transition into resident endothelial cells during compensatory lung growth.
CD34 is necessary for efficient muscle regeneration in adult mice.
We conclude that CD34 is expressed by mucosal Dendritic Cells and plays an important role in their trafficking through the lung and to the lymph nodes.
RUNX1 (show RUNX1 ELISA Kits) regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element
Expression of CD34 and MMP-9 (show MMP9 ELISA Kits) accurately predicts clinical behavior detection and prognosis of GCTBs.
Expression of VEGF (show VEGFA ELISA Kits) and CD34 was critically correlated with perioperative hemorrhage in gastric cancer patients.
There was significant correlation between age and tumor size with CD34 expression in oral SCC (show CYP11A1 ELISA Kits) samples and no significant correlation between sex and tumor differentiation level. Also, there was no significant correlation between age, sex, tumor size and tumor differentiation level (grading) with CD34 expression in esophagus SCC (show CYP11A1 ELISA Kits) samples.
Normal FLT3 (show FLT3 ELISA Kits) and negative expression of CD34 and cMPL (show MPL ELISA Kits) may predict a longer overall survival in aute myeloid leukemia (show BCL11A ELISA Kits).
High VEGF (show VEGFA ELISA Kits) expression was subsequently correlated with a short overall survival rate for patients exhibiting lymph node metastasis (P=0.0128); however, there was no significant difference in overall survival rate regarding the expression levels of TP and CD34
Metformin simultaneously increases VEGFA (show VEGFA ELISA Kits) and reduces CXCL10 (show CXCL10 ELISA Kits) and TIMP1 (show TIMP1 ELISA Kits) in CD34(+) cells in a model of the diabetic state combined with hypoxia to stimulate angiogenesis.
Immunohistochemistry results indicate that combination with ALDH1 (show ALDH1A1 ELISA Kits) and STAT6 (show STAT6 ELISA Kits) can improve the diagnostic value of CD34 for solitary fibrous tumors.
CD34(+) cells lowering expression of TET2 (show TET2 ELISA Kits) may play an oncogenic role on myeloid tumor and CD3 (show CD3 ELISA Kits)(+) T cells of myelodysplastic syndrome patients may be derived from the malignant clone.
ICAM-1 (show ICAM1 ELISA Kits), VCAM-1 (show VCAM1 ELISA Kits) and CD34 are useful biomarkers in evaluation of vascular and inflammatory lesions such as gingival pyogenic granuloma and the results indicate the role of these biomarkers in pathogenesis of oral pyogenic granuloma.
Studied the relationship between serum alkaline phosphatase, circulating CD34-positive cells and body mass index.
There is an association with CD34 immunostaining and ischemic injury of pedicle flaps.
These results suggest that CD34 may be involved in mediating the cell-to-cell adhesion between trophectoderm and the luminal epithelial cells during early pregnancy in pigs.
Combination of anti-CD34 antibody and drug-eluting stents reduces risk of coronary restenosis.
Immobilization of anti-CD34 antibody on sirolimus-eluting stents enhances endothelialization and may potentially be an effective therapeutic alternative to improve currently available drug-eluting stents.
The protein encoded by this gene may play a role in the attachment of stem cells to the bone marrow extracellular matrix or to stromal cells. This single-pass membrane protein is highly glycosylated and phosphorylated by protein kinase C. Two transcript variants encoding different isoforms have been found for this gene.
, cluster designation 34
, hematopoietic progenitor cell antigen CD34
, hematopoietic progenitor cell marker CD34